C

Clinresco Centres | Kempton Park, South Africa

Research site
(Unclaimed)
Location
Central Professional Suites, 1st floor 20 Central avenue, Kempton Park, Gauteng, South Africa
Site insights

Top conditions

COVID-19 (2 trials)

Urinary Tract Infections (1 trial)

Rheumatoid Arthritis (1 trial)

Arthritis (1 trial)

Human Influenza (1 trial)

Top treatments

Levofloxacin
Ritlecitinib
LY3009104
Baricitinib
Eravacycline

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo

Enrolling
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Placebo
Drug: Ritlecitinib
Locations recently updated

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

Trial sponsors

Pfizer logo

Pfizer (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems